잠시만 기다려 주세요. 로딩중입니다.
KMID : 0359019890090020195
Korean Journal of Gastrointestinal Endoscopy
1989 Volume.9 No. 2 p.195 ~ p.201
Clinical Study of KU-54(Aplace(r)) in Gastric Ulcer
원종호/Won JH
김진홍/이문성/조성원/심찬섭/Kim JH/Lee MS/Cho SW/Shim CS
Abstract
Although our present knowledge of the etiology of peptic ulcer is incomplete, the presence or absence of peptic ulcer is determined by the delicate interplay between aggressive factors (secreted gastric acid and pepsin) and defensive factors (mucosal resistance). Peptic ulcer is produced when the aggressive effects of acid-pepsin dominate the protective effects of gastric or duodenal mucosal resistance by predominance of aggressive factors or interruption of defensive factors. KU-54 enhances mucosal resistance to tissue injury by the increase of gastric mucosal blood flow, the stimulation of gastric mucosal metabolism, the increase of glycoprotein of gastric mucus, and the increase of ATP of gastric mucosa. We have treated 38 cases of gastric ulcers with KU-54 300 mg daily for 4-12 weeks for the evaluation of the therapeutic efficacy. Endoscopic, clinical, and laboratory assessments were undergone before and after 4 ~ 12 weeks of the treatment. Major symptoms of gastric ulcer have been improved in 83.3% after the medication with KU-54. The healing rate of gastric ulcer evaluated by endoscopy was observed in 33.3% after 4 weeks, 73.3% after 8 weeks, 76.6% after 12 weeks of the medication with KU-54. The utility rate of KU-54 was 86.7%. We could conclude that KU-54 is the utilizable drug for gastric ulcer.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
학술진흥재단(KCI) KoreaMed 대한의학회 회원